RPSA as a Potential Prognostic Biomarker of Pancreatic Cancer
NCT04575363
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
90
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Ductal Adenocarcinoma (PDAC)
Interventions
OTHER:
Blood sample
Sponsor
CHU de Reims